Dongying Ti&Ong Pharmaceutial Co.,Ltd
Dongying Ti&Ong Pharmaceutical Co., Ltd. is identified in source materials as a Chinese pharmaceutical entity with a focus on heparin-related products. The company is described as being founded in 1992 and operating under the Shandong Haike chemical group, designated as a national high-tech enterprise. The principal product lines highlighted include sodium heparin, enoxaparin sodium, heparin sodium, and nadroparin calcium. These items indicate a specialization in anticoagulant active pharmaceutical ingredients (APIs) and related raw materials. The profile notes that the organization serves as a supplier of domestic low molecular weight heparin raw materials, with a distribution reach that extends to more than 40 countries and regions around the world. While the available information confirms a global export footprint and a focus on heparin-derived products, it does not provide additional details on manufacturing capacity, quality certifications, or specific regulatory approvals.
Given the limited public data, the description presents the entity as a pharmaceutical materials supplier with an established international trading footprint and a strategic connection to a larger chemical group, emphasizing its role in the supply of heparin-related APIs and raw materials. The content suggests that the company operates within the pharmaceutical supply chain, potentially involving activities such as material synthesis, quality control, regulatory compliance, and international logistics to support exports. No further operational specifics, market segments, or service offerings beyond the listed products are documented in the provided sources.
In summary, the profile indicates a China-based supplier of heparin-related APIs and raw materials with decades of operation, operating under a known chemical group and maintaining a global export presence.
